| Selumetinib |
ENSG00000031544.10 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000088970.11 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000117242.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000125804.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000126005.11 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000157306.10 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000157306.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000167912.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000172250.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000172250.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000172250.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000172965.10 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000174365.15 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000175873.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000177337.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000177337.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000177738.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000177738.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000178193.5 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000178412.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000178440.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000178803.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000178947.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000179141.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000179406.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000179406.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000179743.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000179743.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000179818.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000179818.9 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000179859.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000179859.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000181097.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000181798.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000182021.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000182021.5 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000182165.13 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000182586.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000184068.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000184068.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000185044.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000186019.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000186056.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000186615.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000188185.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000188365.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000188825.9 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000189238.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000196243.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000196559.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000196559.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000196696.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000196696.8 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000196972.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000197558.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000197670.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000203321.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000203327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000203362.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000203364.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000203446.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000203721.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000203739.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000203875.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000204054.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000204055.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000204241.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000204380.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000204623.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000204625.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000204666.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000204837.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000204929.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000204934.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000205500.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000205628.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000205890.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000211683.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000212163.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000213742.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000213863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000214146.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000214184.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000214347.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000214407.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000214407.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000214432.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000214546.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000214548.10 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000214650.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000214837.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000214837.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000214922.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000214955.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000214955.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000215039.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000215244.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000215256.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000215458.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000215692.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000215692.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000215841.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000215859.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000217258.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000217576.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000218510.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000221817.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000222041.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000222043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000222043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000222044.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000223356.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000223374.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000223374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000223379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000223393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000223393.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000223440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000223442.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000223461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000223462.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000223462.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000223473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000223473.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000223522.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000223525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000223528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000223571.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000223586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000223635.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000223642.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000223714.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000223759.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000223764.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000223791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000223799.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000223842.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000223842.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000223884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000223935.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000224023.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000224050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224174.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000224271.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000224356.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000224358.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000224376.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000224429.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000224429.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000224429.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000224460.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000224460.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224505.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000224533.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000224533.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000224597.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000224606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224687.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000224713.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224714.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224764.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000224812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000224818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224818.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000224843.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000224848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000224884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000224897.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000224905.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000224905.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224914.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000224939.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000224945.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000224959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000224959.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000224961.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000225039.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000225057.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000225138.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000225146.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000225163.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000225180.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225206.4 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000225218.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000225235.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000225265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000225331.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000225353.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225361.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000225377.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000225439.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225442.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000225442.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000225518.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000225518.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000225518.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000225527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000225541.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000225578.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000225579.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225746.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000225751.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000225767.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000225778.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000225783.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000225793.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000225793.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000225850.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225857.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000225860.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225867.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000225905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000225963.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000225978.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000225981.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000226009.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000226137.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000226137.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000226179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000226179.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000226263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000226263.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000226310.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000226312.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000226328.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000226330.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000226381.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000226416.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000226445.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000226471.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000226471.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000226471.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000226505.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000226505.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000226508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000226519.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000226533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000226648.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000226659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000226684.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000226686.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000226690.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000226786.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000226803.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000226819.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000226833.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000226851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000226851.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000226852.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000226853.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000226856.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000226864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000226877.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000226877.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000226877.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000226883.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000226891.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000226913.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000226950.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227014.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000227060.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000227107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227155.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000227170.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000227170.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000227175.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000227188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227200.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227245.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000227256.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000227279.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227354.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000227359.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000227375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000227375.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000227375.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000227403.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000227431.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227432.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000227480.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227495.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000227512.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000227527.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000227543.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000227591.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000227598.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000227617.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000227617.4 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000227627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227637.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227733.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000227741.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000227773.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000227857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227888.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000227959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228037.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000228061.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000228063.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000228086.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000228107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000228109.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000228113.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228115.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000228126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228140.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000228201.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000228214.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000228274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228274.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000228302.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000228315.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000228327.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000228327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000228352.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000228363.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000228369.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000228414.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000228506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228509.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000228526.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228544.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000228577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228604.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000228624.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000228629.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228629.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000228634.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000228737.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000228748.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000228748.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000228801.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000228809.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000228839.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000228839.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000228852.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000228857.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000228878.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000228878.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000228886.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000228889.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000228889.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000229017.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000229043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229056.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000229056.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000229111.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000229122.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229124.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000229127.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229152.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000229180.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000229311.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229348.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229454.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000229463.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000229487.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000229539.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229539.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000229582.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000229582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000229582.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000229587.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000229672.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000229692.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229692.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000229697.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000229697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000229728.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229728.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000229750.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000229807.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000229832.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000229891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000229950.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000229956.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000229983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000229989.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000229989.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000229999.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000230024.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000230068.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000230084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000230091.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000230102.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000230107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000230177.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000230186.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230289.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000230303.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000230337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000230366.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000230368.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000230513.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000230513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230534.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000230537.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000230606.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000230613.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000230613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000230699.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000230699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230736.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000230736.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000230806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230850.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000230910.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230912.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000230925.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000230939.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000230943.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000230943.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000231028.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231064.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000231073.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000231081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000231083.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000231102.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000231104.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000231172.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000231226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000231233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000231242.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231305.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000231312.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231329.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000231363.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000231365.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000231393.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000231483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000231507.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000231521.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000231527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000231530.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000231551.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000231566.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000231566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000231574.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000231607.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000231616.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000231616.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000231616.4 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000231628.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000231636.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000231654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000231689.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000231703.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000231728.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000231728.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000231731.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000231764.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000231764.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231768.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000231770.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231806.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231842.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000231856.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231865.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000231868.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000231871.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000231881.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000231889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000231889.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000231889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000231908.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000231966.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000231993.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000232023.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000232063.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232082.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000232098.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232104.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000232116.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232116.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000232118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000232151.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000232194.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000232224.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000232274.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000232284.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232295.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000232336.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000232342.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000232352.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000232412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000232412.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000232453.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000232485.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000232485.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000232487.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000232519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000232527.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232533.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000232542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000232600.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000232611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000232618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000232618.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000232618.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000232623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000232640.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000232645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232645.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000232692.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000232860.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232900.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000232934.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000232949.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000232956.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000232977.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000232995.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000232995.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000233013.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000233017.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000233080.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000233081.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000233178.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000233220.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000233237.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000233242.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000233250.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000233251.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000233296.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000233360.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000233363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000233396.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000233427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000233429.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000233429.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000233429.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000233430.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000233515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000233515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000233547.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000233611.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000233613.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000233654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000233672.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000233799.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000233806.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000233817.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000233845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000233847.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000233854.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000233901.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000233912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000233930.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000233967.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000234006.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000234006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234028.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000234072.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000234155.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000234155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000234171.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000234183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000234197.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000234206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234222.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000234292.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000234418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234459.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000234492.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000234492.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000234509.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000234546.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234617.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234630.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000234684.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000234689.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000234694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000234695.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000234705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234753.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234772.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000234793.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000234793.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000234832.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000234859.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000234869.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000234869.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000234900.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000234917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000234936.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000234945.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000235072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000235078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000235092.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235117.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000235123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000235159.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000235189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000235204.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235257.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000235257.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235262.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000235277.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235280.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000235280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000235298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000235313.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235373.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000235397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000235398.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000235408.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000235408.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000235419.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000235445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000235448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000235450.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000235461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000235477.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000235477.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000235488.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000235488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000235493.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235501.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235501.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000235527.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235532.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000235545.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000235590.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000235629.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000235635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000235659.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000235706.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000235724.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000235823.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000235872.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000235897.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000235904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000235958.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000235989.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000235999.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000236008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000236051.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000236051.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000236064.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000236064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236078.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000236173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236200.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000236234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000236255.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000236266.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000236269.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000236305.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000236305.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236308.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000236318.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000236345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236423.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000236426.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000236432.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000236434.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000236453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236472.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000236526.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000236537.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000236601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000236687.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236703.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000236708.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000236778.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000236799.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000236830.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000236850.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000236861.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000236901.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236914.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000236935.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000236943.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000237036.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000237074.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237094.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000237094.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000237094.7 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237166.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237222.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000237280.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000237310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000237310.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000237343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000237399.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000237402.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000237438.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000237453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000237491.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000237502.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000237502.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000237512.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000237523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000237525.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237525.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000237587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237686.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000237689.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000237697.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000237705.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000237707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000237753.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000237781.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000237807.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000237813.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000237819.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000237845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237877.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000237899.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000237903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237937.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237943.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000237976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000237998.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000238035.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000238058.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000238120.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000238123.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000238141.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000238142.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000238221.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000238224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000238280.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000239002.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000239265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000239300.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000239445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000239445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000239462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000239462.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000239593.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000239593.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000239608.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000239608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000239641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000239653.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000239705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000239774.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000239828.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000239920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000240005.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000240057.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000240063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000240137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000240219.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000240219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000240440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000240476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000240497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000240571.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000240618.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000240618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000240758.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000240758.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000240758.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000240758.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000240922.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000241135.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000241155.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000241180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000241280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000241288.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000241481.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000241520.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000241544.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000241732.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000241860.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000241886.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000241954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000242049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000242082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000242125.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000242125.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000242154.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000242207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000242288.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000242349.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000242375.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000242474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000242686.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000242753.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000242797.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000242798.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000243089.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000243176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000243224.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000243224.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000243350.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000243415.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000243479.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000243485.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000243701.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000243795.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000243819.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000243849.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000243926.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000243926.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000244063.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000244124.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000244184.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000244184.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000244198.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000244203.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000244219.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000244300.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000244327.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000244380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000244558.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000244625.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000244625.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000244625.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000244945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000244952.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000245080.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000245112.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000245146.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000245149.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000245213.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000245213.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000245281.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000245468.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000245468.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000245498.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000245498.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000245532.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000245552.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000245694.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000245694.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000245729.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000245729.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000245750.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000245750.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000245954.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000246067.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000246174.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000246228.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000246308.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000246375.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000246523.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000246582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000246627.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000246640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000246662.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000246731.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000246731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000246859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000246877.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000246898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000246982.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000246982.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000246985.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000247011.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000247081.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000247137.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000247151.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000247199.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000247213.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000247287.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000247373.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000247400.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000247516.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000247516.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000247556.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000247572.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000247595.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000247595.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000247679.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000247708.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000247735.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000248019.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000248079.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000248092.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000248103.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000248174.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000248256.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000248268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000248356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000248445.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000248445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000248476.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000248544.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000248544.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000248554.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000248671.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000248671.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000248714.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000248714.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000248734.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000248740.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000248758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000248774.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000248787.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000248925.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000248932.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000248936.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000248936.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000248996.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000249159.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000249167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000249167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000249167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000249207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000249216.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000249234.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000249234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000249252.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000249307.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000249328.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000249359.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000249359.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000249407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000249456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000249492.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000249526.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000249595.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000249641.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000249647.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000249650.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000249684.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000249685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000249740.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000249740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000249782.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000249791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000249846.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000249859.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000249894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000249896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000249898.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000249906.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000249916.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000249917.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000249942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000250015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000250027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000250041.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000250049.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000250061.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000250073.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000250107.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000250132.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000250220.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000250222.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000250240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000250286.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000250312.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000250320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000250404.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000250432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000250451.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000250451.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000250451.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000250490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000250490.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000250614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000250616.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000250635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000250699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000250714.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000250742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000250764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000250765.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000250770.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000250802.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000250899.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000250899.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000250920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000250948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000250950.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251018.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000251023.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000251075.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000251131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251161.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251179.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000251194.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000251279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000251307.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000251323.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251330.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000251330.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251364.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000251405.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000251408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000251414.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000251414.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251556.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251562.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000251577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251584.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000251603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000251615.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251623.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000251661.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000251661.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000251661.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000251666.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000251666.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000251675.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000251680.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000251867.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000253111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253112.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000253141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253174.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000253187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253197.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000253263.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000253284.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000253317.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000253347.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000253390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253477.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253552.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000253562.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000253567.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000253591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253596.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000253616.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000253616.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253649.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000253658.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000253671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000253704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000253716.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000253737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253773.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000253773.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000253799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253837.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000253844.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000253848.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000253854.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000253854.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000253865.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253893.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000253898.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000253911.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000253921.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000253930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253948.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000253972.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000253978.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000253986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000254044.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000254154.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000254162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000254224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000254226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000254233.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000254286.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000254290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000254340.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000254363.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000254370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000254397.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000254414.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000254419.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000254468.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000254480.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000254528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000254560.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000254577.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000254602.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000254605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000254606.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000254610.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000254631.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000254671.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000254676.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000254812.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000254837.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000254879.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000254900.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000254907.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000254910.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000254910.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000254929.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000254934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000254967.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000254973.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000254991.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000255008.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000255020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000255089.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000255094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000255120.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000255139.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000255142.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000255142.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000255153.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000255158.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000255202.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000255234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000255237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000255318.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000255328.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000255337.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000255337.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000255343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000255366.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000255367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000255409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000255421.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000255443.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000255487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000255521.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000255568.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000255568.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000255669.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000255741.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000255843.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000255843.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000255847.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000255867.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000255893.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000255893.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000255920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000255933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000255992.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000256050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000256083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000256139.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000256155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000256250.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000256268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000256299.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000256417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000256588.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000256596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000256742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000256967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000257038.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000257038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000257135.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000257151.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000257176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000257221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000257222.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000257261.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000257264.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000257283.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000257298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000257329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000257337.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000257354.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000257366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000257366.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000257366.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000257391.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000257410.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000257410.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000257449.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000257449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000257449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000257474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000257475.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000257526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000257534.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000257543.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000257556.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000257563.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000257671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000257702.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000257754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000257754.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000257759.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000257824.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000257829.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000257900.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000257913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000257924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000257964.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000258001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000258048.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000258057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000258077.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000258082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000258183.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258274.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000258301.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000258325.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000258354.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000258428.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000258428.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000258428.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000258450.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000258454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000258457.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000258553.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000258561.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000258592.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000258593.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000258623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000258670.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000258673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000258711.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000258717.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000258736.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000258754.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000258791.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258819.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000258831.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000258851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000258858.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258858.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000258884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000258891.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000258922.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000258957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000258982.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000258999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000259006.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000259031.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000259054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259081.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000259083.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000259115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259116.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000259129.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000259172.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259206.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000259212.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000259212.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000259219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259242.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259244.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259251.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000259287.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000259294.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000259310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000259310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259319.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259322.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000259343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000259349.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000259354.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259366.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259408.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000259416.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000259422.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000259448.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000259488.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000259587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259595.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000259623.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000259635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259659.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000259692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000259694.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000259705.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000259723.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000259723.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000259727.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000259732.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000259736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259758.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000259760.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000259762.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000259767.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000259767.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259768.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000259775.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000259792.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000259792.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000259804.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000259818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259834.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000259867.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000259877.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000259881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000259901.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000259921.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000259935.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000260037.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260038.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260038.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000260051.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260051.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260052.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000260059.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260083.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260084.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260136.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260179.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000260196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260213.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000260236.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000260252.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000260257.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260257.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000260261.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260269.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260279.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260288.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260296.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000260296.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260306.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260306.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260328.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260329.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260336.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260351.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000260352.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260404.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260411.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260418.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260423.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000260425.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260425.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260447.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000260455.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260464.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260464.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000260470.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260470.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260498.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000260528.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260565.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260581.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000260583.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260589.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000260591.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260597.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260608.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260618.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260625.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260626.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000260626.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000260630.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000260637.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260641.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260645.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000260646.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260647.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260648.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260657.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260661.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260672.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260742.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260743.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000260766.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260773.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260778.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260787.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260790.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260793.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260803.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000260803.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260807.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260830.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260830.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000260837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260838.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260840.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260855.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000260871.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000260884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260891.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000260917.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000260923.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000260927.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260932.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260973.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000260996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000260996.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000261005.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261005.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261094.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000261096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000261096.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261098.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261114.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261117.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261124.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000261126.3 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000261141.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000261159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261167.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261173.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261187.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261187.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000261189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261195.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000261200.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261211.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000261220.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261251.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261254.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000261270.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261291.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261302.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000261326.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261342.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000261355.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261366.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000261372.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261372.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000261379.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261386.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261396.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261407.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000261420.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261455.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000261474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000261476.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261481.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000261488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261488.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261488.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000261505.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261505.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000261529.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261529.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000261560.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261568.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000261572.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261595.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261596.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261613.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261662.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261663.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261664.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000261692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261723.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261758.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261760.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261766.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261799.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261801.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261840.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000261840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000261842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000261879.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261924.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000261924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261971.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000261971.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000261996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000262038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000262074.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000262117.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000262147.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000262152.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000262155.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000262172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000262194.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000262298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000262339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000262343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000262454.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000262468.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000262521.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000262619.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000262652.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000262652.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000262678.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000262692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000262703.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000262703.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000262703.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000262768.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000262772.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000262772.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000262786.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000262833.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000262877.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000262877.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000262879.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000262952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000262966.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000262973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000262979.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000263004.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000263050.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000263098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000263164.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000263214.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000263220.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000263272.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000263280.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000263280.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000263345.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000263393.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000263400.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000263466.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000263551.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000263603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000263612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000263627.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000263657.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000263683.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000263718.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000263753.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000263847.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000263847.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000263862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000263884.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000263916.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000263924.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000263975.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000263982.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000264107.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000264112.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000264167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000264235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000264290.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000264304.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000264365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000264491.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000264514.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000264548.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000264548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000264569.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000264575.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000264635.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000264672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000264673.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000264769.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000264860.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000264860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000264868.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000264937.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000264937.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000264940.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000265008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000265205.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000265342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000265399.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000265443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000265443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000265458.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000265474.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000265479.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000265511.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000265666.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000265778.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000265845.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000265845.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000265907.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000265908.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000265912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000265912.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000266040.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000266040.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000266079.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000266088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000266176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000266236.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000266236.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000266261.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000266289.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000266289.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000266313.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000266411.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000266445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000266469.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000266498.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000266654.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000266667.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000266709.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000266729.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000266805.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000266821.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000266824.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000266869.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000266933.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000266934.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000266936.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000266950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000266969.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000266969.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000266970.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000266999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267002.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267003.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000267042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267067.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267080.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267089.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000267093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000267100.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267104.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267104.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267123.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000267141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267143.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000267147.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000267161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267161.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267169.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000267183.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267194.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000267221.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000267221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267222.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000267230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000267244.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000267248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000267249.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267277.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267277.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000267278.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000267278.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267287.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267288.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267298.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000267299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267302.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000267311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267322.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000267348.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000267348.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267348.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267374.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000267405.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000267414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000267419.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267429.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000267454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000267474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000267479.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000267481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000267510.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000267519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267530.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267532.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000267546.2 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000267547.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000267560.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000267563.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000267566.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000267588.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000267613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000267637.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000267644.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000267654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000267655.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000267658.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000267682.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000267715.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000267715.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000267730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000267765.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000267776.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000267834.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267858.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267868.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000267904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000267939.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000268001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000268006.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000268027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000268027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000268047.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000268049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000268095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000268157.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000268262.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000268266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000268289.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000268307.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000268401.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000268564.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000268605.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000268670.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000268670.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000268743.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000268812.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000268812.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000268895.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000268913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000268945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000268947.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000268970.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000269051.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000269172.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000269352.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000269386.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000269392.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000269416.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000269463.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000269486.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000269600.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000269792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000269815.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000269836.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000269836.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000269894.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000269895.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000269896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000269901.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000269902.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000269902.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000269921.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000269938.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000269944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000269946.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000269946.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000269956.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000269971.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000269973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000269979.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000269980.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000269990.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000270006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000270015.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000270015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000270015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000270018.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000270028.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000270048.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000270061.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000270061.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000270069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000270069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270083.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270091.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270102.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000270104.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270105.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270109.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000270124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000270145.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000270154.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000270159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000270165.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270174.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000270184.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270190.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000270210.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270246.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000270344.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270362.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000270419.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270426.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000270462.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000270462.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000270571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000270580.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270604.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270605.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270605.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000270641.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000270697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270704.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000270720.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000270726.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000270761.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000270820.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000271119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271119.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000271119.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000271199.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000271234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000271335.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000271344.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000271387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271398.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000271398.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000271533.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000271551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000271553.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000271555.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000271576.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000271734.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271743.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000271752.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000271755.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000271757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000271816.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000271825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271833.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000271835.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000271840.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000271848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271851.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000271851.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000271862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000271871.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000271874.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000271888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000271889.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000271914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271926.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000271927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271948.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271964.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000271967.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000271971.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000271975.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000271975.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000271978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000271978.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000271978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000271992.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272005.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272009.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272029.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272076.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000272079.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000272091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000272097.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272103.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000272109.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272137.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272140.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272181.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272203.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000272216.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000272216.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000272216.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272225.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000272233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272250.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272312.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272320.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272335.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272371.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272374.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272379.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272447.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272463.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000272468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000272473.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272485.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000272489.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272508.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000272524.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272525.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272556.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272588.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000272610.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000272622.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000272644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000272645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272662.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000272668.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000272669.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272688.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272690.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000272692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272695.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000272695.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000272702.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272717.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272719.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272720.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272735.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000272755.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272788.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000272791.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272800.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000272829.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272834.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000272836.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000272836.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272848.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272849.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000272855.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000272859.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272892.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272902.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000272905.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000272908.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000272927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000272933.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000272940.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000272942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000272945.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000272949.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000272954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000272979.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000273000.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273014.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273014.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000273015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000273026.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273027.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000273032.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273032.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Selumetinib |
ENSG00000273059.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000273066.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273075.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273075.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Selumetinib |
ENSG00000273076.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000273081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273081.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273104.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000273107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000273118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273132.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000273139.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000273142.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273145.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273145.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000273153.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000273156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273188.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000273230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273240.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000273253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273271.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000273284.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000273287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000273290.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273297.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000273302.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000273302.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000273311.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000273311.1 |
Predicted lncRNA |
Sarcoma |
|
| Selumetinib |
ENSG00000273328.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
ENSG00000273329.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000273342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Selumetinib |
ENSG00000273343.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000273343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Selumetinib |
ENSG00000273344.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273368.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273374.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000273375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273381.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Selumetinib |
ENSG00000273402.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273472.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Selumetinib |
ENSG00000273472.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Selumetinib |
ENSG00000273476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Selumetinib |
ENSG00000273483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Selumetinib |
ENSG00000273486.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Selumetinib |
ENSG00000273493.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Selumetinib |
hsa-miR-105-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-140-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-146a-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-148b-3p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-185-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-204-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-211-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-301a-3p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-30c-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-361-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-362-3p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-484 |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-502-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-506-3p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-509-3-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-509-3p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-514a-3p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-532-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-551b-3p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-582-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-584-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-652-3p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-660-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
hsa-miR-9-5p |
predicted miRNA |
NCI60 |
|
| Selumetinib |
miR-17 |
Curated miRNA |
lung cancer |
|